Terahertz (THz) radiation, which occupies the frequency band between microwaves and infrared light, is essential in many next ...
The Pu Solar Panel Frame Market market is integral to the expansion of solar energy projects worldwide. Its growth is driven by increasing investments in clean energy, technological advancements, and ...
Neumora expects to initiate a clinical program evaluating NMRA-215 monotherapy and combination therapy for the treatment of obesity in the first half of 2026. The Company expects to report weight loss ...
Based on the feedback from the FDA, the Company’s regulatory data package would be sufficient for the submission of an NDA for AXS-12 for the treatment of cataplexy in narcolepsy. Axsome anticipates ...
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a stock dividend of one share of common stock for every 1,000 shares of outstanding common stock as well as one share ...
Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.
Researchers developed a liquid chromatography tandem mass spectrometry (LC-MS/MS) assay for the simultaneous measurement of 11 types of estrogen from song sparrows using derivatization with ...
It’s been a dream run for this leading man. A decade since he broke through with Masaan, he recently had his greatest success with Chhaava. He is that rare combination: an actor and a star.
Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.
. ├── main.py # Main entry point ├── src/ # Source code │ └── rf_cavity_env.py # RF cavity environment implementation ├── scripts/ # Training and testing scripts │ ├── train_rf_cavity.py # Training ...
Abstract: We propose in this paper a highly linear dual-drive silicon-on-insulator Mach-Zehnder modulator (MZM) assisted by a micro-ring resonator for the microwave photonics and the integrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results